MBL Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
MBL Wealth's ABBV Position: Q2 2026 in Review
MBL Wealth reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $212K and leaving 7,862 shares worth $1.98M. The position accounts for 0.14% of the portfolio, ranked #91.
MBL Wealth first reported a position in ABBV in Q1 2021 and has held it in 19 quarters since. The position peaked at $2.03M in Q4 2025. 2,254 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- MBL Wealth held 7,862 shares of AbbVie worth $1.98M as of Q2 2026.
- MBL Wealth sold 984 AbbVie shares in Q2 2026, an estimated $212K.
- AbbVie made up 0.14% of MBL Wealth's portfolio in Q2 2026, its #91 holding.
- MBL Wealth first reported a position in AbbVie in Q1 2021 and has held it in 19 quarters since.
- MBL Wealth's AbbVie position peaked at $2.03M in Q4 2025.
- 2,254 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.